Ledige stillinger
Utforsk mulighetene hos Novartis her.
Showing 408 results
- Sort by Sort ascending
- Stillingstittel Sorter stigende
- Avdeling
- Land
- Sted
- Dato publisert
| Stillingstittel Sorter stigende | Avdeling | Land | Sted | Dato publisert |
|---|---|---|---|---|
| Radioligand Therapies (RLT) Associate Director, Priority Accounts - Virginia - Carolinas Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | des 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts – Texas Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | des 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts – Phoenix Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | des 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts - Pennsylvania Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | des 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts – Pacific NW Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | des 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts - Boston, MA Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | des 02, 2025 |
| Director, Business Excellence Lead, ASCVD Regular, Full time | General Management | USA | East Hanover | des 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts - Mid - Atlantic Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | des 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts - Columbus, Ohio Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | des 02, 2025 |
| Associate Director Evidence Partnerships & Solutions Regular, Full time | Development | India | Hyderabad (Office) | des 02, 2025 |